Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Wilms tumor of the kidney characterized by the predominance of the mesenchymal component.
Biomarker and diagnostic research for stromal predominant kidney Wilms tumor has been reported in the published literature.
No clinical trials have been registered for stromal predominant kidney Wilms tumor.
7 publications have been identified in PubMed for stromal predominant kidney Wilms tumor. Research spans Case Report / Case Series (71%), Diagnostic / Biomarker (14%), and Clinical Trial Publication (14%).
Siddiqui U (2026). [PMID: 41837194](https://pubmed.ncbi.nlm.nih.gov/41837194/). *Front Pediatr*. [Case Report / Case Series]
Erickson A (2026). [PMID: 41768351](https://pubmed.ncbi.nlm.nih.gov/41768351/). *Urol Case Rep*. [Case Report / Case Series]
Gupta A (2025). [PMID: 39323382](https://pubmed.ncbi.nlm.nih.gov/39323382/). *Cytopathology*. [Case Report / Case Series]
Götz L (2025). [PMID: 39740515](https://pubmed.ncbi.nlm.nih.gov/39740515/). *Transl Oncol*. [Diagnostic / Biomarker]
Škarda J (2025). [PMID: 40177273](https://pubmed.ncbi.nlm.nih.gov/40177273/). *Front Med (Lausanne)*. [Case Report / Case Series]
Data assembled from 2 of 12 sources · Last updated Sep 19, 2026, 9:43 PM UTC
Duncan C (2024). [PMID: 38539045](https://pubmed.ncbi.nlm.nih.gov/38539045/). *J Natl Cancer Inst*. [Clinical Trial Publication]